342 related articles for article (PubMed ID: 32485920)
1. A Tale of Two Proteolytic Machines: Matrix Metalloproteinases and the Ubiquitin-Proteasome System in Pulmonary Fibrosis.
Roque W; Boni A; Martinez-Manzano J; Romero F
Int J Mol Sci; 2020 May; 21(11):. PubMed ID: 32485920
[TBL] [Abstract][Full Text] [Related]
2. Fine-tuning the ubiquitin-proteasome system to treat pulmonary fibrosis.
Roque W; Summer R; Romero F
Connect Tissue Res; 2019 Jan; 60(1):50-61. PubMed ID: 30343604
[TBL] [Abstract][Full Text] [Related]
3. Matrix metalloproteinases as therapeutic targets for idiopathic pulmonary fibrosis.
Craig VJ; Zhang L; Hagood JS; Owen CA
Am J Respir Cell Mol Biol; 2015 Nov; 53(5):585-600. PubMed ID: 26121236
[TBL] [Abstract][Full Text] [Related]
4. Role of matrix metalloproteinases in the pathogenesis of idiopathic pulmonary fibrosis.
Pardo A; Cabrera S; Maldonado M; Selman M
Respir Res; 2016 Mar; 17():23. PubMed ID: 26944412
[TBL] [Abstract][Full Text] [Related]
5. Cell-specific expression of runt-related transcription factor 2 contributes to pulmonary fibrosis.
Mümmler C; Burgy O; Hermann S; Mutze K; Günther A; Königshoff M
FASEB J; 2018 Feb; 32(2):703-716. PubMed ID: 28986417
[TBL] [Abstract][Full Text] [Related]
6. Increased AGE-RAGE ratio in idiopathic pulmonary fibrosis.
Machahua C; Montes-Worboys A; Llatjos R; Escobar I; Dorca J; Molina-Molina M; Vicens-Zygmunt V
Respir Res; 2016 Nov; 17(1):144. PubMed ID: 27816054
[TBL] [Abstract][Full Text] [Related]
7. Pivotal role of matrix metalloproteinase 13 in extracellular matrix turnover in idiopathic pulmonary fibrosis.
Nkyimbeng T; Ruppert C; Shiomi T; Dahal B; Lang G; Seeger W; Okada Y; D'Armiento J; Günther A
PLoS One; 2013; 8(9):e73279. PubMed ID: 24023851
[TBL] [Abstract][Full Text] [Related]
8. The aged extracellular matrix and the profibrotic role of senescence-associated secretory phenotype.
Mebratu YA; Soni S; Rosas L; Rojas M; Horowitz JC; Nho R
Am J Physiol Cell Physiol; 2023 Sep; 325(3):C565-C579. PubMed ID: 37486065
[TBL] [Abstract][Full Text] [Related]
9. Matrix metalloproteinase: An upcoming therapeutic approach for idiopathic pulmonary fibrosis.
Mahalanobish S; Saha S; Dutta S; Sil PC
Pharmacol Res; 2020 Feb; 152():104591. PubMed ID: 31837390
[TBL] [Abstract][Full Text] [Related]
10. Lung Fibroblasts, Aging, and Idiopathic Pulmonary Fibrosis.
Pardo A; Selman M
Ann Am Thorac Soc; 2016 Dec; 13 Suppl 5():S417-S421. PubMed ID: 28005427
[TBL] [Abstract][Full Text] [Related]
11. Regulation of 26S Proteasome Activity in Pulmonary Fibrosis.
Semren N; Welk V; Korfei M; Keller IE; Fernandez IE; Adler H; Günther A; Eickelberg O; Meiners S
Am J Respir Crit Care Med; 2015 Nov; 192(9):1089-101. PubMed ID: 26207697
[TBL] [Abstract][Full Text] [Related]
12. Contributions of alveolar epithelial cell quality control to pulmonary fibrosis.
Katzen J; Beers MF
J Clin Invest; 2020 Oct; 130(10):5088-5099. PubMed ID: 32870817
[TBL] [Abstract][Full Text] [Related]
13. Molecular Pathogenesis of Pulmonary Fibrosis, with Focus on Pathways Related to TGF-β and the Ubiquitin-Proteasome Pathway.
Inui N; Sakai S; Kitagawa M
Int J Mol Sci; 2021 Jun; 22(11):. PubMed ID: 34198949
[TBL] [Abstract][Full Text] [Related]
14. Metalloproteinases in idiopathic pulmonary fibrosis.
Dancer RC; Wood AM; Thickett DR
Eur Respir J; 2011 Dec; 38(6):1461-7. PubMed ID: 21700608
[TBL] [Abstract][Full Text] [Related]
15. TBK1 regulates YAP/TAZ and fibrogenic fibroblast activation.
Aravamudhan A; Haak AJ; Choi KM; Meridew JA; Caporarello N; Jones DL; Tan Q; Ligresti G; Tschumperlin DJ
Am J Physiol Lung Cell Mol Physiol; 2020 May; 318(5):L852-L863. PubMed ID: 32159970
[TBL] [Abstract][Full Text] [Related]
16. Extracellular Matrix Cross-Linking Enhances Fibroblast Growth and Protects against Matrix Proteolysis in Lung Fibrosis.
Philp CJ; Siebeke I; Clements D; Miller S; Habgood A; John AE; Navaratnam V; Hubbard RB; Jenkins G; Johnson SR
Am J Respir Cell Mol Biol; 2018 May; 58(5):594-603. PubMed ID: 29053339
[TBL] [Abstract][Full Text] [Related]
17. Role of matrix metalloprotease-2 and MMP-9 in experimental lung fibrosis in mice.
Bormann T; Maus R; Stolper J; Tort Tarrés M; Brandenberger C; Wedekind D; Jonigk D; Welte T; Gauldie J; Kolb M; Maus UA
Respir Res; 2022 Jul; 23(1):180. PubMed ID: 35804363
[TBL] [Abstract][Full Text] [Related]
18. Azithromycin attenuates myofibroblast differentiation and lung fibrosis development through proteasomal degradation of NOX4.
Tsubouchi K; Araya J; Minagawa S; Hara H; Ichikawa A; Saito N; Kadota T; Sato N; Yoshida M; Kurita Y; Kobayashi K; Ito S; Fujita Y; Utsumi H; Yanagisawa H; Hashimoto M; Wakui H; Yoshii Y; Ishikawa T; Numata T; Kaneko Y; Asano H; Yamashita M; Odaka M; Morikawa T; Nakayama K; Nakanishi Y; Kuwano K
Autophagy; 2017 Aug; 13(8):1420-1434. PubMed ID: 28613983
[TBL] [Abstract][Full Text] [Related]
19. Osteopontin: an essential regulatory protein in idiopathic pulmonary fibrosis.
Zhu X; Ji J; Han X
J Mol Histol; 2024 Feb; 55(1):1-13. PubMed ID: 37878112
[TBL] [Abstract][Full Text] [Related]
20. Regulation of Cellular Senescence Is Independent from Profibrotic Fibroblast-Deposited ECM.
Blokland KEC; Habibie H; Borghuis T; Teitsma GJ; Schuliga M; Melgert BN; Knight DA; Brandsma CA; Pouwels SD; Burgess JK
Cells; 2021 Jun; 10(7):. PubMed ID: 34209854
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
